A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group.

@article{Schmidt1991ARC,
  title={A randomized, controlled trial of prophylactic ganciclovir for cytomegalovirus pulmonary infection in recipients of allogeneic bone marrow transplants; The City of Hope-Stanford-Syntex CMV Study Group.},
  author={Gerhard M. Schmidt and David A. Horak and Joyce C. Niland and Steven R. Duncan and Stephen J. Forman and John A Zaia},
  journal={The New England journal of medicine},
  year={1991},
  volume={324 15},
  pages={1005-11}
}
BACKGROUND Cytomegalovirus (CMV)-associated interstitial pneumonia is a major cause of death after allogeneic bone marrow transplantation. We conducted a controlled trial of ganciclovir in recipients of bone marrow transplants who had asymptomatic pulmonary CMV infection. We also sought to identify risk factors for the development of CMV interstitial pneumonia. METHODS After bone marrow transplantation, 104 patients who had no evidence of respiratory disease underwent routine bronchoalveolar… CONTINUE READING
147 Citations
0 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 147 extracted citations

Similar Papers

Loading similar papers…